Diet and inflammation score in women at high breast cancer risk
Part of Cancer, Skin clinical trials.
This study looks at whether a person’s diet that tends to cause more body inflammation is linked to future breast cancer risk. It may help researchers understand how eating patterns could affect risk in people already considered high-risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Be followed at OSU’s high-risk breast clinic or Stefanie Spielman Comprehensive Breast Center high-risk clinic
- Have one of these breast risk diagnoses: ADH, ALH, LCIS, sclerosing adenosis, or radial scars
- Not have a personal history of ductal carcinoma in situ (DCIS) or invasive breast cancer
- Be able to read, speak, and understand English and sign consent to continue follow-up using your medical records
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how environmental exposures might affect breast cancer risk. It includes women at average risk, high risk, or those diagnosed with breast cancer before age 50, as well as healthcare providers.
This trial tests whether a white button mushroom powder supplement can lower inflammation in postmenopausal women who have a high risk of breast cancer. If it helps, it could improve early prevention strategies for people at higher risk.
This study tests whether low-dose tamoxifen (a breast cancer prevention drug) or omega-3 supplements can lower breast cancer risk in postmenopausal women who are overweight and have a higher chance of getting the disease. The study lasts about 6 months and involves blood draws and a breast fluid test to see how the treatment affects breast cells.
This study looks at how inflammation and social factors (like stress or support) affect breast cancer patients before they start treatment. You may qualify if you are a woman, newly diagnosed, and have not yet had any cancer treatment.
This study tests whether a special anti-inflammatory diet can help reduce side effects in breast cancer survivors who are taking aromatase inhibitors after menopause. You would be randomly assigned to either follow the diet for 6 months or continue your usual diet, and your health will be monitored.
This trial looks at how your body's daily habits and subtle inflammation may affect your risk for heart disease and related conditions. You'll use a mobile app to log your food intake and help researchers understand individual factors that influence low-grade inflammation.
Hear when a new Breast Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.